University of California San Francisco
Give to UCSF
From prostate cancer to immunotherapy to genetic testing, UCSF research is providing new insights and aiding in the development of new treatment strategies for cancer.
Researchers at UCSF, UC Berkeley and partner institutions are receiving $6 million to help address three neglected tropical diseases that place a huge health and economic burden on people in Central and South America: Chagas’ disease, dengue and onchocerciasis.
Harvey V. Fineberg, MD, PhD, MPP, the President of the Institute of Medicine, will come to UCSF for a yearlong appointment as a Presidential Chair beginning in September.
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? UCSF ob/gyn Karen Smith-McCune, MD, PhD, weighs in.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
As we mark World Malaria Day this year, UCSF’s Global Health Group is celebrating the success of Namibia, where malaria case have dropped 98 percent over the past decade.
Premature birth is the leading cause of death for newborns, yet most of those lives can be saved. UCSF Benioff Children's Hospitals are launching a 10-year initiative to address this global problem.
UCSF has been selected to join a national “dream team” on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.
In an innovative clinical trial led by UCSF, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
CVS Caremark, the nation’s largest pharmacy health care company, and UCSF's Steven Schroeder say selling tobacco products is “clearly antithetical” to the role of pharmacies.
